MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Case Report: An Unusual Case of Corticobasal Syndrome

    A. Ly, M. King, C. Sherer, J. Crook, A. Schindler, L. Danielian, K. Porter, A. Snyder, J. Kwan, S. Scholz (Bethesda, USA)

    Objective: To describe a patient with corticobasal syndrome (CBS) and biomarker evidence of multiple proteinopathies. Background: CBS is a clinically heterogeneous syndrome caused by several…
  • 2024 International Congress

    Parkinsonism Associated with Twinkle Gene Mutation

    C. Felin, B. Oliveira, Y. Borges, S. Trentin (Porto Alegre, Brazil)

    Objective: To describe a rare manifestation of Twinkle gene mutation causing not only progressive external ophthalmoplegia (PEO), but also parkinsonism. Background: PEO is one of…
  • 2024 International Congress

    Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

    S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)

    Objective: This study compares Parkinson's disease (PD) and parkinsonian syndromes (PS) in patients at a Kyrgyzstan university hospital. It analyzes data from 2016-2017 [1] and…
  • 2024 International Congress

    24 Hour Maxillofacial Administration of Levodopa in a Parkinsons Patient -An Alternative Route of Administration in Parkinsons Disease

    S. Thirunavukarasu, B. Ramanan, V. Varadharaj, TS. Suresh, KV. Verma, HAJ. Janardhanan, AUR. Ur (PUDUCHERRY, India)

    Objective: To assess tolerability, feasibility, safety and to assess outcome measures clinically as well as by serum levels over 24 hours, using the alternative maxillofacial…
  • 2024 International Congress

    Clinical and Brain Morphological Characteristics of Early LRRK2-associated Parkinson Disease

    Q. Tao, S. Rahayel, C. Tremblay, A. Vo, A. Dagher (Montreal, Canada)

    Objective: To investigate the impact of LRRK2 mutation in Parkinson disease (PD) and to explore the preclinical markers of LRRK2 mutation carriers who will develop…
  • 2024 International Congress

    Sex differences of gait at self-determined speed in neurodegenerative parkinsonism

    F. Jagusch, V. Sidoroff, G. Prigent, H. Moradi, S. Sapienza, JP. Ndayisaba, F. Krismer, H. Humer, P. Bachmann, K. Seppi, I. Teckenburg, M. Asalian, D. Benninger, BM. Eskofier, J. Winkler, J. Klucken, H. Gassner, A. Ionescu, K. Aminian, C. Raccagni, GK. Wenning (Innsbruck, Austria)

    Objective: To identify sex-specific differences in observer-independent gait parameters in parkinsonian disorders. Background: Reduced mobility and gait impairment impact the quality of life and increase…
  • 2024 International Congress

    Leveraging Large-Scale Proteomics to Identify Protein Quantitative Trait Loci and Causal Effects on Parkinson’s Disease

    M. Lai, B. Benitez (Boston, USA)

    Objective: Integrate proteomics from the cerebrospinal fluid (CSF) and urine from the Parkinson’s Progression Markers Initiative cohort to prioritize the risk variants associated with Parkinson’s…
  • 2024 International Congress

    Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

    G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)

    Objective: To describe 5 late-onset sporadic cases carrying either biallelic or monoallelic variants in ATP13A2, showing either spastic ataxia(Spatax) or primary lateral sclerosis (PLS) as…
  • 2024 International Congress

    Understanding Patient and Care Partner Educational Preferences in Atypical Parkinsonism

    M. Ivancic, M. Comeau, R. Mahabir, C. Malburg, J. Shurer, K. Woods, E. Zivin, CY. Lin (Chapel Hill, USA)

    Objective: To discern preferences for education and community connection among people affected by progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or multiple system atrophy (MSA).…
  • 2024 International Congress

    Peripheral immune profile and neutrophil-to-lymphocyte ratio in Progressive Supranuclear Palsy

    L. Muñoz-Delgado, A. Luque-Ambrosiani, B. Benítez Zamora, D. Macías-García, S. Jesús, AD. Adarmes‐gómez, E. Ojeda-Lepe, F. Carrillo, P. Mir (Sevilla, Spain)

    Objective: This study aimed to evaluate the peripheral immune profile in patients with Progressive Supranuclear Palsy (PSP) compared with patients with Parkinson’s disease (PD) and…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley